Item

Correlation between immune-related adverse events (irAEs) and survival outcomes in extensive-stage small cell lung cancer (ES-SCLC) patients (pts) treated with chemoimmunotherapy (CT-IO)

Monaca, F.
; 
Gomez-Randulfe, I.
; 
Parreira, A. S.
; 
Longo, V.
; 
Galetta, D.
; 
Pilotto, S.
; 
Polidori, S.
; 
Cosmai, A.
; 
Stefani, A.
; 
Vita, E.
... show 9 more
Citations
Altmetric:
Abstract
Authors
Monaca, F.
Gomez-Randulfe, I.
Parreira, A. S.
Longo, V.
Galetta, D.
Pilotto, S.
Polidori, S.
Cosmai, A.
Stefani, A.
Vita, E.
Taylor, P.
Gomes, F.
Hughes, S.
Cove-Smith, L.
Summers, Y.
Blackhall, F.
Tortora, G.
Bria, E.
Califano, R.
Affiliation
Fdn Policlin Univ A Gemelli IRCCS, Med Oncol Dept, Rome, Italy Christie NHS Fdn Trust, Med Oncol Dept, Manchester, England Ist Tumori Bari Giovanni Paolo II IRCCS, Med Thorac Oncol Unit, Bari, Italy Univ Verona, Med Dept, Med Oncol Sect, UNIVR, Verona, Italy
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Monaca F, Gomez-Randulfe I, Parreira AS, Longo V, Galetta D, Pilotto S, et al. Correlation between immune-related adverse events (irAEs) and survival outcomes in extensive-stage small cell lung cancer (ES-SCLC) patients (pts) treated with chemoimmunotherapy (CT-IO). JOURNAL OF THORACIC ONCOLOGY. 2025 MAR;20(3). PubMed PMID: WOS:001464133600009. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627621
Embedded videos